Cargando…
Partial-Methylated HeyL Promoter Predicts the Severe Illness in Egyptian COVID-19 Patients
BACKGROUND: To date (14 January 2022), the incidence and related mortality rate of COVID-19 in America, Europe, and Asia despite administrated of billions doses of many approved vaccines are still higher than in Egypt. Epigenetic alterations mediate the effects of environmental factors on the regula...
Autores principales: | Fadel, Hewida H., Ahmed, Mohammad Abd EL-Rahman, Gharbeya, Kareem Mahamoud, Mohamed, Mohammed Ahmed Khamis, Roushdy, Mohamed N., Almiry, Reda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153385/ https://www.ncbi.nlm.nih.gov/pubmed/35655915 http://dx.doi.org/10.1155/2022/6780710 |
Ejemplares similares
-
Sox9 Inhibits Cochlear Hair Cell Fate by Upregulating Hey1 and HeyL Antagonists of Atoh1
por: Veithen, Mona, et al.
Publicado: (2023) -
Sustained expression of HeyL is critical for the proliferation of muscle stem cells in overloaded muscle
por: Fukuda, Sumiaki, et al.
Publicado: (2019) -
Notch3 regulates Mybl2 via HeyL to limit proliferation and tumor initiation in breast cancer
por: Brahim, Sonia, et al.
Publicado: (2023) -
The HeyL-Aromatase Axis Promotes Cancer Stem Cell Properties by Endogenous Estrogen-Induced Autophagy in Castration-Resistant Prostate Cancer
por: Lin, Qimei, et al.
Publicado: (2022) -
The impact of vitamin D supplementation on peripheral neuropathy in a sample of Egyptian prediabetic individuals
por: Reda Halawa, Mohamed, et al.
Publicado: (2021)